The top 12 advances in vascular medicine

Jeffrey W. Olin, James Jang, Michael R. Jaff, Joshua A. Beckman, Thom W Rooke

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

In the past decade, impressive strides have been made in the diagnosis and management of atherosclerotic, aneurysmal, and thromboembolic diseases, thanks in large part to the explosive growth in both vascular biology and clinical vascular medicine. We review what we consider to be the top 12 advances in this field: the discovery of nitric oxide, the metabolic syndrome, new thrombophilic disorders, therapeutic angiogenesis, endoluminal treatment of chronic venous disease, and a variety of drugs, including sildenafil, cilostazol, low-molecular-weight heparins, oral direct thrombin inhibitors, clopidogrel, statins, and angiotensin-converting enzyme inhibitors and angiotensin-receptor blocking agents.

Original languageEnglish (US)
JournalJournal of Endovascular Therapy
Volume11
Issue numberSUPPL. 2
StatePublished - Dec 2004

Fingerprint

clopidogrel
Cardiology
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Angiotensin Receptors
Antithrombins
Low Molecular Weight Heparin
Clinical Medicine
Angiotensin-Converting Enzyme Inhibitors
Blood Vessels
Nitric Oxide
Chronic Disease
Therapeutics
Growth
Pharmaceutical Preparations
cilostazol
Sildenafil Citrate

Keywords

  • ACE inhibitors
  • Angiogenesis
  • Angiotensin-receptor blocking agents
  • Cilostazol
  • Clopidogrel
  • Low-molecular-weight heparin
  • Metabolic syndrome
  • Nitric oxide
  • Peripheral artery disease
  • Sildenafil
  • Statins
  • Vascular biology
  • Vascular medicine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Olin, J. W., Jang, J., Jaff, M. R., Beckman, J. A., & Rooke, T. W. (2004). The top 12 advances in vascular medicine. Journal of Endovascular Therapy, 11(SUPPL. 2).

The top 12 advances in vascular medicine. / Olin, Jeffrey W.; Jang, James; Jaff, Michael R.; Beckman, Joshua A.; Rooke, Thom W.

In: Journal of Endovascular Therapy, Vol. 11, No. SUPPL. 2, 12.2004.

Research output: Contribution to journalReview article

Olin, JW, Jang, J, Jaff, MR, Beckman, JA & Rooke, TW 2004, 'The top 12 advances in vascular medicine', Journal of Endovascular Therapy, vol. 11, no. SUPPL. 2.
Olin JW, Jang J, Jaff MR, Beckman JA, Rooke TW. The top 12 advances in vascular medicine. Journal of Endovascular Therapy. 2004 Dec;11(SUPPL. 2).
Olin, Jeffrey W. ; Jang, James ; Jaff, Michael R. ; Beckman, Joshua A. ; Rooke, Thom W. / The top 12 advances in vascular medicine. In: Journal of Endovascular Therapy. 2004 ; Vol. 11, No. SUPPL. 2.
@article{d4e3a274a5714c25a94eb98300ebc482,
title = "The top 12 advances in vascular medicine",
abstract = "In the past decade, impressive strides have been made in the diagnosis and management of atherosclerotic, aneurysmal, and thromboembolic diseases, thanks in large part to the explosive growth in both vascular biology and clinical vascular medicine. We review what we consider to be the top 12 advances in this field: the discovery of nitric oxide, the metabolic syndrome, new thrombophilic disorders, therapeutic angiogenesis, endoluminal treatment of chronic venous disease, and a variety of drugs, including sildenafil, cilostazol, low-molecular-weight heparins, oral direct thrombin inhibitors, clopidogrel, statins, and angiotensin-converting enzyme inhibitors and angiotensin-receptor blocking agents.",
keywords = "ACE inhibitors, Angiogenesis, Angiotensin-receptor blocking agents, Cilostazol, Clopidogrel, Low-molecular-weight heparin, Metabolic syndrome, Nitric oxide, Peripheral artery disease, Sildenafil, Statins, Vascular biology, Vascular medicine",
author = "Olin, {Jeffrey W.} and James Jang and Jaff, {Michael R.} and Beckman, {Joshua A.} and Rooke, {Thom W}",
year = "2004",
month = "12",
language = "English (US)",
volume = "11",
journal = "Journal of Endovascular Therapy",
issn = "1526-6028",
publisher = "International Society of Endovascular Specialists",
number = "SUPPL. 2",

}

TY - JOUR

T1 - The top 12 advances in vascular medicine

AU - Olin, Jeffrey W.

AU - Jang, James

AU - Jaff, Michael R.

AU - Beckman, Joshua A.

AU - Rooke, Thom W

PY - 2004/12

Y1 - 2004/12

N2 - In the past decade, impressive strides have been made in the diagnosis and management of atherosclerotic, aneurysmal, and thromboembolic diseases, thanks in large part to the explosive growth in both vascular biology and clinical vascular medicine. We review what we consider to be the top 12 advances in this field: the discovery of nitric oxide, the metabolic syndrome, new thrombophilic disorders, therapeutic angiogenesis, endoluminal treatment of chronic venous disease, and a variety of drugs, including sildenafil, cilostazol, low-molecular-weight heparins, oral direct thrombin inhibitors, clopidogrel, statins, and angiotensin-converting enzyme inhibitors and angiotensin-receptor blocking agents.

AB - In the past decade, impressive strides have been made in the diagnosis and management of atherosclerotic, aneurysmal, and thromboembolic diseases, thanks in large part to the explosive growth in both vascular biology and clinical vascular medicine. We review what we consider to be the top 12 advances in this field: the discovery of nitric oxide, the metabolic syndrome, new thrombophilic disorders, therapeutic angiogenesis, endoluminal treatment of chronic venous disease, and a variety of drugs, including sildenafil, cilostazol, low-molecular-weight heparins, oral direct thrombin inhibitors, clopidogrel, statins, and angiotensin-converting enzyme inhibitors and angiotensin-receptor blocking agents.

KW - ACE inhibitors

KW - Angiogenesis

KW - Angiotensin-receptor blocking agents

KW - Cilostazol

KW - Clopidogrel

KW - Low-molecular-weight heparin

KW - Metabolic syndrome

KW - Nitric oxide

KW - Peripheral artery disease

KW - Sildenafil

KW - Statins

KW - Vascular biology

KW - Vascular medicine

UR - http://www.scopus.com/inward/record.url?scp=12144284867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144284867&partnerID=8YFLogxK

M3 - Review article

C2 - 15760260

AN - SCOPUS:12144284867

VL - 11

JO - Journal of Endovascular Therapy

JF - Journal of Endovascular Therapy

SN - 1526-6028

IS - SUPPL. 2

ER -